Biotech News
MediciNova Appoints Dr. Christopher Breder, MD, PhD as Clinical and Regulatory Advisor
investors.medicinova.com2026-05-06 15:07 EST
LA JOLLA, Calif. , Nov. 18, 2025 (GLOBE NEWSWIRE) -- MediciNova, Inc. , a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the Standard Market of the Tokyo Stock Exchange (Code Number: 4875), is pleased to announce the appointment of Dr. Christopher D.